Wolff Wiese Magana’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-450
Closed -$3.02K 725
2023
Q4
$3.02K Hold
450
﹤0.01% 439
2023
Q3
$2.53K Hold
450
﹤0.01% 520
2023
Q2
$2.48K Hold
450
﹤0.01% 528
2023
Q1
$2.81K Hold
450
﹤0.01% 489
2022
Q4
$2.1K Hold
450
﹤0.01% 496
2022
Q3
$2K Hold
450
﹤0.01% 710
2022
Q2
$3K Sell
450
-22
-5% -$245 ﹤0.01% 690
2022
Q1
$9K Sell
472
-325
-41% -$7.45K 0.01% 549
2021
Q4
$26K Sell
797
-286
-26% -$11.5K 0.02% 378
2021
Q3
$44K Sell
1,083
-7,955
-88% -$289K 0.03% 295
2021
Q2
$325K Buy
9,038
+263
+3% +$9.71K 0.23% 92
2021
Q1
$342K Sell
8,775
-7,735
-47% -$348K 0.27% 81
2020
Q4
$666K Buy
+16,510
New +$759K 0.56% 52

Other funds holding GDRX

Wolff Wiese Magana's GDRX Position: Q1 2024 in Review

Wolff Wiese Magana sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 450 shares — an estimated $3.02K sold.

Wolff Wiese Magana first reported a position in GDRX in Q4 2020 and held it in 13 quarters. The position peaked at $666K in Q4 2020. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • Wolff Wiese Magana reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
  • Wolff Wiese Magana sold 450 GoodRx Holdings shares in Q1 2024, an estimated $3.02K.
  • Wolff Wiese Magana first reported a position in GoodRx Holdings in Q4 2020 and held it in 13 quarters.
  • Wolff Wiese Magana's GoodRx Holdings position peaked at $666K in Q4 2020.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Wolff Wiese Magana's 13F filing for Q1 2024, filed 18 Apr 2024.